AB42/40
Concept
A biomarker for Alzheimer's disease, the ratio of amyloid-beta peptides 42 to 40, which improved with Obicetrapib treatment.
Mentioned in 1 video
A biomarker for Alzheimer's disease, the ratio of amyloid-beta peptides 42 to 40, which improved with Obicetrapib treatment.